CA
JNJ icon

Clune & Associates’s Johnson & Johnson JNJ Stock Holding History

Clune & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$244K Sell
922
-54
-6% -$14.2K 0.04% 147
2026
Q2 		$248K Sell
976
-247
-20% -$57.6K 0.04% 154
2026
Q1 		$299K Buy
+1,223
New +$285K 0.06% 140

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
PineStone Asset Management
PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Clune & Associates's JNJ Position: Q3 2026 in Review

Clune & Associates reduced its Johnson & Johnson (JNJ) stake by 5.5% in Q3 2026, selling an estimated $14.2K and leaving 922 shares worth $244K. The position accounts for 0.04% of the portfolio, ranked #147.

Clune & Associates first reported a position in JNJ in Q1 2026 and has held it in 3 quarters since. The position peaked at $299K in Q1 2026. 1,262 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Clune & Associates held 922 shares of Johnson & Johnson worth $244K as of Q3 2026.
  • Clune & Associates sold 54 Johnson & Johnson shares in Q3 2026, an estimated $14.2K.
  • Johnson & Johnson made up 0.04% of Clune & Associates's portfolio in Q3 2026, its #147 holding.
  • Clune & Associates first reported a position in Johnson & Johnson in Q1 2026 and has held it in 3 quarters since.
  • Clune & Associates's Johnson & Johnson position peaked at $299K in Q1 2026.
  • 1,262 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Clune & Associates's 13F filing for Q3 2026, filed 8 Oct 2026.